Tamara Ortíz
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Genetics 6
- Inflammatory Bowel Disease 4
-
- Coenzyme Q10 studies and effects 2
- Co-authors
- Ana Alcudia (6 shared papers)Belén Begines (3 shared papers)Manuel Merinero (3 shared papers)María Pérez‐Aranda (2 shared papers)Guillermo Martínez (2 shared papers)Federico Argüelles‐Arias (4 shared papers)Eva M. Pérez-Soriano (1 shared paper)Paul K. Witting (5 shared papers)
In The Last Decade
Tamara Ortíz
21 papers receiving 986 citations
Tamara Ortíz's Hit Papers
Peers
Comparison fields: 5 of 134
- Pharmaceutical Science 165
- Biomaterials 315
- Drug Discovery 2
- Molecular Medicine 54
- Biomedical Engineering 250
Countries citing papers authored by Tamara Ortíz
This map shows the geographic impact of Tamara Ortíz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Ortíz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Ortíz more than expected).
Fields of papers citing papers by Tamara Ortíz
This network shows the impact of papers produced by Tamara Ortíz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Ortíz. The network helps show where Tamara Ortíz may publish in the future.
Co-authors
The 25 scholars most cited alongside Tamara Ortíz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects Hit paper breakdown → | 2020 | 674 |
| 2 | 2020 | 164 | |
| 3 | 2022 | 29 | |
| 4 | 2020 | 20 | |
| 5 | 2017 | 19 | |
| 6 | Autohemotherapy with ozone as a possible effective treatment for Fibromyalgia. | 2020 | 18 |
| 7 | 2015 | 17 | |
| 8 | 2021 | 14 | |
| 9 | 2016 | 13 | |
| 10 | 2017 | 9 | |
| 11 | 2024 | 8 | |
| 12 | 2025 | 6 | |
| 13 | 2023 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2008 | 3 | |
| 16 | 2018 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2015 | 1 | |
| 20 | 2023 | 1 |
About Tamara Ortíz
Tamara Ortíz is a scholar working on Genetics, Molecular Biology, Epidemiology, Immunology and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Down syndrome and intellectual disability research (2 papers), Vitamin D Research Studies (2 papers), Microscopic Colitis (2 papers), Coenzyme Q10 studies and effects (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Aging, Health, and Disability (2 papers) and Chronic Disease Management Strategies (2 papers). The work is most often cited by research in Pharmaceutical Science (165 citations), Biomaterials (315 citations), Drug Discovery (2 citations), Molecular Medicine (54 citations) and Biomedical Engineering (250 citations). Tamara Ortíz has collaborated with scholars based in Spain, Chile and Australia. Frequent co-authors include Ana Alcudia, Belén Begines, Manuel Merinero, María Pérez‐Aranda, Guillermo Martínez, Federico Argüelles‐Arias, Eva M. Pérez-Soriano, Paul K. Witting, Manuel de Miguel and María Isabel Hodgson. Their work appears in journals such as Redox Report, Bioscience Reports, Advances in experimental medicine and biology, Frontiers in Immunology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.